{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-22-001940","form_type":"8-K","ticker":"UG","cik":"0000101295","company_name":"UNITED GUARDIAN INC","filed_at":"2022-03-17T23:59:59+00:00","discovered_at":"2026-05-14T18:04:05.047720+00:00","generated_at":"2026-06-26T21:52:40.549152+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"United-Guardian FY 2021 net income up 41%; revenue +27% to $13.9M","bullets":["Net income of $4.66M ($1.01/share) vs $3.30M ($0.72) in 2020, a 41% increase.","Net sales rose 27% to $13.93M from $10.99M; cosmetic ingredient sales surged 61%.","Sales to China rebounded; European sales increased 42% with UK up 42%.","Medical product sales grew 6%; pharmaceutical sales remained strong through pandemic.","Management optimistic for continued growth in 2022 with new product development."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-22-001940","json":"https://secwatch.observer/filing/0001171843-22-001940.json","markdown":"https://secwatch.observer/filing/0001171843-22-001940.md","text":"https://secwatch.observer/filing/0001171843-22-001940.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/101295/000117184322001940/0001171843-22-001940-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/101295/000117184322001940/f8k_031622.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T21:52:40.549152+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}